Affordability Check
How to afford BIVALIRUDIN
Generic name: Bivalirudin
Pick how you're covered. We'll show you the cheapest legitimate way to get BIVALIRUDIN — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About BIVALIRUDIN and its cost
What is this medication? Bivalirudin is an intravenous anticoagulant medication primarily used in medical settings for patients undergoing percutaneous coronary intervention, commonly referred to as angioplasty. It belongs to a specific class of drugs known as direct thrombin inhibitors. The primary purpose of the medication is to prevent the formation of harmful blood clots during these cardiac procedures by blocking the chemical reactions that cause blood to thicken and clot.
In addition to its standard use during angioplasty, bivalirudin is frequently used as a safer alternative to heparin for patients who have a history of heparin-induced thrombocytopenia. It works by binding directly to thrombin, the enzyme in the blood that is responsible for converting fibrinogen into fibrin, which is the foundation of a blood clot. By inhibiting this process, the drug helps ensure that blood continues to flow freely through the arteries while a surgeon or cardiologist is working on the heart, significantly lowering the risk of procedural complications.
BIVALIRUDIN is made by a pharmaceutical manufacturer. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford BIVALIRUDIN?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for BIVALIRUDIN?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But the manufacturer has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover BIVALIRUDIN?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Thrombocytopenia?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about BIVALIRUDIN
Full BIVALIRUDIN drug page
FDA label, prior authorization rules, full indications list
More options for Thrombocytopenia
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3